APA

Huerga H., Mueller Y., Ferlazzo G., Mpala Q., Bevilacqua P., Vasquez B., Noël Mekiedje C., Ouattara A., Mchunu G., Weyenga H. O., Varaine F. & Bonnet M. (20160706). Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings. : Journal of acquired immune deficiency syndromes (1999).

Chicago

Huerga Helena, Mueller Yolanda, Ferlazzo Gabriella, Mpala Qhubekani, Bevilacqua Paolo, Vasquez Béatrice, Noël Mekiedje Calorine, Ouattara Ali, Mchunu Gugu, Weyenga Herman O, Varaine Francis and Bonnet Maryline. 20160706. Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings. : Journal of acquired immune deficiency syndromes (1999).

Harvard

Huerga H., Mueller Y., Ferlazzo G., Mpala Q., Bevilacqua P., Vasquez B., Noël Mekiedje C., Ouattara A., Mchunu G., Weyenga H. O., Varaine F. and Bonnet M. (20160706). Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings. : Journal of acquired immune deficiency syndromes (1999).

MLA

Huerga Helena, Mueller Yolanda, Ferlazzo Gabriella, Mpala Qhubekani, Bevilacqua Paolo, Vasquez Béatrice, Noël Mekiedje Calorine, Ouattara Ali, Mchunu Gugu, Weyenga Herman O, Varaine Francis and Bonnet Maryline. Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings. : Journal of acquired immune deficiency syndromes (1999). 20160706.